![Fred G. Weiss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fred G. Weiss
Directeur/Membre du Conseil chez
The Michael J. Fox Foundation for Parkinson's Research
Profil
Fred G.
Weiss is currently the Director at The Michael J.
Fox Foundation for Parkinson's Research and the Managing Director at Fgw Consultancy LLC.
He previously served as Vice Chairman at BlackRock CoRI Funds from 2013 to 2017, Independent Director at Actavis, Inc. from 2011 to 2013, Director at BTG Ltd. from 2001 to 2007, and Independent Director at Allergan Ltd. (Ireland) from 2000 to 2018.
He was also the Managing Director at FGW Associates, Inc. and an Independent Non-Executive Director at RVL Pharmaceuticals Plc from 2018 to 2021.
Prior to these roles, he was the VP-Planning, Investment & Development at Warner-Lambert Co. from 1979 to 1996.
Mr. Weiss received his undergraduate degree from the University of Pennsylvania and his MBA from The University of Chicago.
Postes actifs de Fred G. Weiss
| Sociétés | Poste | Début |
|---|---|---|
The Michael J. Fox Foundation for Parkinson's Research
 The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services Finds a cure for Parkinson’s disease | Directeur/Membre du Conseil | 01/01/2000 |
Fgw Consultancy LLC | Corporate Officer/Principal | - |
Anciens postes connus de Fred G. Weiss
| Sociétés | Poste | Fin |
|---|---|---|
| RVL PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 04/11/2021 |
| ALLERGAN PLC | Directeur/Membre du Conseil | 31/10/2018 |
BlackRock CoRI Funds
 BlackRock CoRI Funds Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Directeur/Membre du Conseil | 01/01/2017 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Directeur/Membre du Conseil | 01/10/2013 |
| BTG | Directeur/Membre du Conseil | 01/01/2007 |
Formation de Fred G. Weiss
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Health Technology |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Health Technology |
BlackRock CoRI Funds
BlackRock CoRI Funds Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies drugs used in the treatment of neurological disorders | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FGW Associates, Inc. | |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services Finds a cure for Parkinson’s disease | Commercial Services |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Fgw Consultancy LLC | |
RVL Pharmaceuticals Plc
 RVL Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
